Filing Flows › Vivos Therapeutics (VVOS) › Next earnings date
Vivos Therapeutics (VVOS) earnings on Nov 16, 2026: what to expect
Vivos Therapeutics (VVOS) is expected to report earnings on Nov 16, 2026 (estimated), in 8 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.32 (−$0.54 to −$0.12, 3 estimates) on revenue of $5.5M, against −$0.49 and $6.8M a year ago. It beat the EPS estimate in 50% of the quarters on record; Filing Flows' model gives it a 64% chance of beating next time.
What to watch
Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$0.49 on revenue of $10.6M, against the analysts' −$0.32.
The last report
Vivos Therapeutics reported revenue of $5.2M for the second quarter 2026 (+35% Y/Y), net loss $5.5M: Service $3.8M, Product $1.4M. How it makes money → · Every quarter →
Vivos Therapeutics' latest quarter
Vivos Therapeutics, Q2 2026: revenue $5.2M (+35% year over year), operating margin -93.6%, net loss $5.5M, operating cash flow −$3.1M. The chart follows the revenue to costs, profit and cash.
Questions
When does VVOS report earnings?
Vivos Therapeutics is expected to report on Nov 16, 2026 (estimated).
What are analysts expecting from Vivos Therapeutics?
EPS of −$0.32 and revenue of $5.5M for the quarter.
Does Vivos Therapeutics usually beat earnings?
It beat the consensus EPS estimate in 50% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.